
On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks. They discuss the challenges of developing products that counter diseases and conditions often steeped in scientific mystery, how AI will help the drug discovery process, the costs of healthcare around the globe, and the mix of traits a CEO needs to lead a pharmaceutical company.
"It's a hugely technical industry. It's also a hugely important human industry. And so we can't lose through that why we're doing what we're doing, which is somebody today is being told you have a terrible neurodegenerative condition or you have obesity and you really should do something about it," said Ricks. "And I think we often have lost our way as an industry or even as a company when we don't pay enough attention to that, which is how we show up in those markets, how we think about introducing our medicines, about integrity, about truthfulness."